Apnimed Inc
D

APMD

18.970
USD
-0.09
(-0.47%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
8,564
الربح لكل سهم
0
العائد الربحي
-
P/E
3
حجم السوق
789,735,878

العنوان: Apnimed Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).